After a detailed review of rising number of cases of mucormycosis in various states, the union government on Saturday allocated a total of 23,680 additional vials of Amphotericin- B to all states and union territories (UTs).
In a tweet, Sadananda Gowda, union minister for chemicals & fertilizers says, "The allocation has been made based on total number of patients which is about 8,848 across country."
Gujarat (5,800) and Maharashtra (5,090) have been allocated the maximum number of the additional Amphotericin-B vials followed by Andhra Pradesh (2,310), Madhya Pradesh (1,830), Rajasthan (1,780), Karnataka (1,270).
Gujarat has reported about 2,281 mucormycosis cases followed by Maharashtra (2,000), Andhra Pradesh (910), Madhya Pradesh (720) Rajasthan (700), Karnataka (5,00), Haryana (250), Delhi (197), Punjab (95), Chhattisgarh (87), Bihar (56), Tamil Nadu (40), Kerala (36), Jharkhand (27), Odisha (15), Goa (12) and Chandigarh (8).
Mucormycosis is a serious but rare fungal infection caused by a group of molds called mucormycetes that has been developing in Covid-19 patients. The fungal disease is commonly being observed in patients, who were given steroids for a long time, who have been hospitalised for a long time, were on oxygen support or ventilator, faced poor hospital hygiene or those who have been taking medication for other illnesses such as diabetes.
If not treated on time, the black fungus infection can turn fatal. The COVID medications can leave the body weak, and low on immunity. They can also escalate the blood sugar levels in both diabetics and non-diabetic COVID patients.